UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Which Index Funds Had Best Yearly Returns Historically reveals top performers by year, helping you compare success across funds.
25,767 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Ethereum slid toward its February trough near $1,700 as broader crypto weakness pressed prices. Yet several analysts ...
A sharp May rally pushed Planet Labs stock higher on renewed growth expectations and a favorable data-demand backdrop...
Bitcoin dipped under $63,000 as oil markets steadied and shipping through the Strait of Hormuz resumed. The move come...
A Dream Finders insider sale grabbed attention after the stock dropped nearly 30%. This guide breaks down what know a...
Two traders file a civil suit accusing Polymarket of misresolving a Strategy bitcoin sale market after a late May dis...
In a volatile market, Procter & Gamble’s decades-long dividend growth and reliable cash flow position it as a stable ...
A legendary friendship reveals powerful money lessons. Learn how trust, communication, and smart risk-taking can stre...
Stocks wobble as a fresh batch of analyst notes lands on top names like Albemarle, American Express and CME Group. He...
Industrial stocks right now offer solid exposure to infrastructure spending and manufacturing demand. Meet two top pi...
Oil stocks COP and Diamondback Energy offer very different risk-and-reward profiles. This guide breaks down cash flow...
AI-driven data centers are lifting utility ETFs higher as power demand climbs. This report analyzes leading funds and...